Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds
Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence
Age Doesn’t Affect Survival After Bone Marrow Transplant
Lenalidomide Found Effective For Lymphoma In Phase II Trial
Intensive Chemo Equivalent To Transplant For MCL
Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant
Arzerra Promising For Heavily Pre-Treated CLL Patients
Dismissed Leukemia Drug Helps CLL, Clinical Trials Find
PDX Shows 27% Response In T-Cell Lymphoma In Study
Second-Generation CML Drugs Show Promise For Frontline
Gleevec To Prevent Recurrence Of Gastrointestinal Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - In the Headlines: Missing record of NCAB meetings restored to NIH website
- Insights from ASCO 2025: Real-world evidence drives clinical decision-making
- In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”
